Filing Details
- Accession Number:
- 0001179110-21-001224
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-02-03 17:03:32
- Reporting Period:
- 2021-02-01
- Accepted Time:
- 2021-02-03 17:03:32
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 815094 | Abiomed Inc | ABMD | Surgical & Medical Instruments & Apparatus (3841) | 042743260 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1200493 | E Dorothy Puhy | C/O Abiomed, Inc. 22 Cherry Hill Drive Danvers MA 01923 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.01 Par Value | Disposition | 2021-02-01 | 1,846 | $345.64 | 6,023 | No | 4 | S | Direct | |
| Common Stock, $0.01 Par Value | Disposition | 2021-02-01 | 1,649 | $351.34 | 4,374 | No | 4 | S | Direct | |
| Common Stock, $0.01 Par Value | Disposition | 2021-02-01 | 1,304 | $351.97 | 3,070 | No | 4 | S | Direct | |
| Common Stock, $0.01 Par Value | Disposition | 2021-02-01 | 201 | $353.07 | 2,869 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock, $0.01 Par Value | 11,335 | Indirect | By Trust |
Footnotes
- Sale of common stock pursuant to reporting owner's 10b5-1 plan.
- This price represents the sale price of the transactions on the reported date at $345.6400. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- This price represents the sale price of the transactions on the reported date at $351.3364. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- This price represents the sale price of the transactions on the reported date at $351.9665. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- This price represents the sale price of the transactions on the reported date at $353.0736. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
Billionaire Hedge Funds
